ANTIPROLIFERATIVE AND DNA CLEAVAGE ACTIVITY OF VARIOUS SOLVENT EXTRACTS OF ACACIA FARNESIANA LINN. POD by Sp, Soul Shekhar et al.
Vol 10, Issue 9, 2017
Online - 2455-3891 
Print - 0974-2441
ANTIPROLIFERATIVE AND DNA CLEAVAGE ACTIVITY OF VARIOUS SOLVENT EXTRACTS OF 
ACACIA FARNESIANA LINN. POD
SOUL SHEKHAR SP1, MANJULATHA K2, SATYANARAYAN ND1*
1Department of Pharmaceutical Chemistry, Kuvempu University, Postgraduate Centre, Kadur, Karnataka, India. 2Department of 
Biochemistry, School of Life Science, University of Hyderabad, Gachibowli, Hyderabad, Telangana, India. Email: satya1782005@gmail.com
Received: 03 May 2017, Revised and Accepted: 26 May 2017
ABSTRACT
Objective: Cancer has become the major disease by uncontrolled cell growth effecting large population on the globe. This study, deals with 
antiproliferative activity of different solvent extracts, viz., n-hexane (S1), dichloromethane (DCM) (S2), and methanol (S3) of Acacia farnesiana 
pod on four cancer cell lines, viz., chronic myelogenous leukemia (K562), breast cancer (MCF-7), hepatocellular carcinoma (HePG2), colorectal 
adenocarcinoma (Colo 205), and DNA cleavage activity of the extracts on CT-DNA.
Methods: The antiproliferative study was performed by MTT assay and DNA cleavage studies of the solvent extracts (S1, S2, and S3) and its fractions (S4 
and S5) was carried out by agarose gel electrophoresis method.
Results: The antiproliferative activity results revealed that n-hexane extract (S1) has showed activity against MCF-7 (21.70 %) cell line and methanol 
extract (S3) against K562 (24.5%) and HePG2 (23.3%) cell lines. The DNA cleavage could be seen at every concentration tested by n-hexane (S1), DCM 
(S2), and methanol (S3) extracts and significant cleavage was observed at concentrations of 25, 50, and 100 µg by fractions (S4) and (S5) of methanol 
extract.
Conclusion: The results indicated that the extract of A. farnesiana pod (n-hexane and methanol) has antiproliferative properties and the DNA cleavage 
studies performed on CT-DNA was found that the extracts and its fractions showed significant activity at the concentrations tested.
Keywords: MTT assay, CT-DNA, Ethidium bromide, Agarose gel electrophoresis, Leukemia, MCF-7 cell line, K562 cell line, HePG2 cell line.
INTRODUCTION
Cancer is one of the most severe diseases in which deregulating 
proliferation of abnormal cells is invading and disrupting surrounding 
tissues [1]. It begins in the cells of the body, where the orderly process is 
disturbed by producing new cells which are not needed and old cells do 
not die thus these extra cells lump together to form a growth of tumor [2]. 
It is the leading cause of morbidity and mortality worldwide with 
approximately 21.7 million new cases, 13 million cancer-related deaths 
and is expected to rise by 70% around 2030 was reported by American 
Cancer Society; 2015 [3]. The partial success of clinical therapies 
including radiation, chemotherapy and surgery in the treatment of 
cancer, indicates that there is an urgent need of alternative strategies 
to control cancer [4]. Medicinal plants have been used as a remedy for 
treating of human diseases for centuries, because of their production of 
new chemical entities as secondary metabolites of therapeutic value [5] 
such as alkaloids, flavonoids, tannins, and phenolics [6]. The secondary 
metabolites display significant activities and play a key role in the 
treatment of cancer [7]. Medicinal plants have become a focal point 
and an important alternative to develop the present and future health 
requirements against cancer; this is because secondary metabolites 
of plants could maintain the health and has the ability to cure various 
diseases, including cancer with less harmful effects [8]. In this regard 
Acacia farnesiana, a medicinally important plant was considered for its 
preliminary investigation for cancer therapy.
A. farnesiana (Linn.) Willd., (Family: Fabaceae) is a thorny bush or small 
tree grows up to 8 m tall throughout tropical parts of Indian subcontinent, 
especially in sandy soils of river beds around north and south India [9]. 
Morphologically the bark is rough and light brown in color. Branches 
are glabrous, purplish to gray, with extremely small glands. Stipules are 
spinescent, usually short, up to 1.8 cm long, rarely longer, never inflated. 
Leaves are twice pinnate, with a small gland on petiole and frequently 
one on the rachis near top of pinnae. Pinnae are 2-8 pairs and leaflets 
are 10-12 pairs which are minute, 2-7 mm long, 0.75-1.75 mm wide, 
glabrous, leathery. Flowers are in axillary pedunculate heads, calyx 
and corolla glabrous, scented. Pods are indehiscent, straight or curved, 
4-7.5 cm length, about 1.5 cm width, dark brown to blackish, glabrous, 
finely longitudinally striate, pointed at both ends. Seeds are chestnut 
brown, in 2 rows, embedded in a dry spongy tissue, 7-8 mm long, 
5.5 mm broad, elliptic, thick, and slightly compressed. Areole 6.5-7 mm 
long, 4 mm wide [10]. A. farnesiana is one of the medicinally important 
plants of Ayurvedic system of medicine and has been used for various 
pharmacological activities such as Vibrio cholera inhibition [11], 
herbicide [12], antimalarial [13], antioxidant [14], antidiarrheal [15], 
antimicrobial [16], phytoremediation [17], defluoridation, 
adsorbent [18], antiulcer [19], acetylcholine esterase, NADH oxidase 
inhibitory [20], bronchodilator [21], and anti-inflammatory [22]. The 
compounds, viz., lectin-like protein, cyclopropenoid fatty acids [23], 
four new diterpenes, acasiane A, acasiane B, farnesirane A, and 
farnesirane B [24], methyl gallate [25], naringenin, kaempferol, 
quercetin, and myricetin [26] have been isolated from various parts 
of the plant. In view of the above fact and literature survey revealed 
that phytochemicals present in A. farnesiana pod are active against 
many pharmacological activities, but so far no investigation on its 
antiproliferative potential has been made. Hence, in this investigation, 




The chemicals used were of analytical grade. Doxorubicin 
(Sigma-Aldrich, USA), Calf-thymus DNA (Bangalore Genei, India), 
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dimethyl sulfoxide (DMSO), agarose, ethidium bromide (ETBr), and 
other chemicals were from (HiMedia Mumbai, India).
Collection of plant material
The pods of A. farnesiana were collected in the month of February-
March-2014 around Kadur town of Chikkamagaluru District, Karnataka 
State, India, and were authenticated with voucher specimen no 
KUYLK4409 at the Herbarium, Department of Botany, Kuvempu 
University, Shankaraghatta, Shimoga Dist. Karnataka State. India.
Preparation of extract [27]
The extraction of the pods was achieved by grinding the material 
of A. farnesiana pods (100 g), packed in Soxhlet extractor and 
extracted successively using different solvent, viz., n-hexane (500 ml), 
dichloromethane (DCM) (500 ml), and methanol (500 ml) with their 
increasing order of polarity. The extraction of A. farnesiana pod was 
carried out by a Soxhlet extraction method successively for about 48 h 
or until the color discharge in the siphon tube of Soxhlet apparatus. The 
yield after evaporation of extracts was n-hexane (S1) (0.45 g), DCM (S2) 
(0.26 g), and methanol (S3) (1.77 g). The obtained extracts were stored 
at −4°C for further analysis.
Preparation of fractions S4 and S5 from A. farnesiana methanol 
extract
The crude methanol extract of A. farnesiana pod was dissolved in 
10% of sodium bicarbonate solution and kept overnight to undergo 
precipitation and later centrifuged to separate the precipitate. The 
precipitate was dissolved in water and extracted with ethyl acetate. The 
ethyl acetate extract was evaporated to dryness, and the dried mass was 
dissolved in methanol to yield two fractions one is methanol soluble 
fraction designated as S4 and another methanol insoluble fraction 
designated as S5.
Phytochemical screening
Preliminary phytochemical screening of A. farnesiana pod was 
performed according to the reported methods of Trease and Evans [28] 
and Harborne [29]. The phytochemical screening results are 
represented in Table 1.
Antiproliferative activity by MTT assay
Cell proliferation is the process where the number of cells increases or 
uncontrolled cell growth takes place due to an imbalance in the cellular 
mechanism, to control the growth of cells antiproliferative measures 
have been carried out using various cell lines [30]. The four different cell 
lines that were used in the study are colorectal adenocarcinoma (Colo 
205); chronic myelogenous leukemia (K562); breast adenocarcinoma 
(MCF7); and hepatocellular carcinoma (HepG2). The cell lines were 
obtained from the National Centre for Cell Sciences, Pune, India, 
and were cultured at a seeding density of 0.2×106 in Dulbecco’s 
modified Eagles Medium/Roswell Park Memorial Institute medium 
supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 
100 µg/ml streptomycin, respectively, maintained in a humidified 
atmosphere with 5% CO2 at 37°C. The samples were dissolved in DMSO 
(DMSO; not exceeding the final concentration of 0.01%) and further 
diluted in cell culture medium. The antiproliferative response of the 
extract was assessed by MTT assay [3-(4, 5-dimethylthiazole-2yl) - 2, 
5-diphenyltetrazolium bromide] [31]. Cells (∼10,000) were plated 
in 200 µl growth medium in the presence or absence of the extract 
(25, 50, 100, and 200 µg/ml) in 96-well culture plates for 24 hrs. Then, 
the culture plates were centrifuged at 2000 rpm for 10 minutes at 
room temperature. Supernatant (100 µl) was discarded, and 20 µl of 
MTT (5 mg/ml in PBS) was added to each well and incubated for 4 hrs 
at 37°C. The viability of the cells was determined at 570 nm using a 
spectrophotometer.
DNA cleavage activity by agarose gel electrophoresis
The extract was added separately to the DNA sample. The sample 
mixtures were incubated at 37°C for 2 hrs. The treatment of DNA samples 
using electrophoresis was done according to the method adopted by 
Sambrook et al. [32]. Weigh 250 mg of agarose and dissolve in 25 ml of 
triacetate ethylenediamine (TAE) buffer (4.84 g Tris base, pH 8.0, 0.5 M 
EDTA/1: l) by gentle heating. As the gel attains ~55°C, pour it into the 
gel cassette fitted with comb and allow solidifying. Carefully remove the 
comb, place the gel in the electrophoresis chamber flooded with TAE 
buffer. Load 20 µl of DNA sample (mixed with bromophenol blue dye at 
1:1 ratio) into the wells, along with DNA marker and pass the constant 
50 V of electricity for around 45 minutes. After 45 minutes remove the 
gel and stain with ETBr solution (10 µg/ml) for 10-15 minutes and 
observe the bands under UV transilluminator.
RESULTS
Phytochemical screening
Phytochemical screening of various solvent extracts of A. farnesiana 
as well as subfractions of the extract was carried out according to 
the methods adopted by Trease and Evans [28] and Harborne [29]. 
The presence of phytochemicals in various solvent extracts reveals 
the class of compounds present. The preliminary screening results 
revealed that the n-hexane and DCM extracts showed the presence of 
steroids, methanol extract revealed the presence of flavonoids, steroids, 
and glycosides whereas the methanol soluble fraction of methanol 
extract revealed the presence of flavonoids and steroids. The methanol 
insoluble portion has shown a positive test for glycosides and saponins.
Antiproliferative activity
The result for antiproliferative activity of various solvent extracts of 
A. farnesiana pod on different cancer cell lines was tested. The n-hexane 
extract (S1) inhibited chronic myelogenous leukemia (K562) by 6.41%, 
hepatocellular carcinoma (HePG2) by 10.81%, breast cancer (MCF-7) 
by 21.7 %, and colorectal adenocarcinoma (Colo 205) by 4.7%. DCM 
extract (S2) inhibited chronic myelogenous leukemia (K562) by 4.93%, 
breast cancer (MCF-7) by 19.36, colorectal adenocarcinoma (Colo 205) 
by 6.93%, and no inhibition against hepatocellular carcinoma (HePG2). 
Methanol extract (S3) inhibited chronic myelogenous leukemia (K562) 
by 24.53%, hepatocellular carcinoma (HePG2) by 23.34%, and breast 
cancer (MCF-7) by 17.6%. The results are represented in Table 2.
DNA cleavage activity
The result for DNA cleavage activity by various solvent extracts of 
A. farnesiana pod demonstrates that n-hexane extract (S1) cleaved the 
DNA at the concentrations tested; DCM extract (S2) also cleaved the 
DNA at the concentrations tested, but a very prominent low molecular 
weight DNA band formation was seen with the increasing concentration 
of the sample. The methanol extract (S3) has increased the DNA cleavage 
potential with an increase in the concentration of the sample. The 
fraction (S4) has shown partial, but significant DNA cleavage as shown 
in Fig. 1 and in fraction (S5) DNA cleavage is significant at 100 µg, but 
other two concentrations yielded less significant cleavage as shown in 
Table 1: Phytochemical screening of various solvent extracts of 
A. farnesiana pod and fraction of methanol extract
Test Phytochemical test S1 S2 S3 S4 S5
Alkaloids Mayer’s test - - - - -
Wagner’s test - - - - -
Flavonoids Ferric chloride test - - + + -
Alkaline test - - + + -
Glycosides Killer-Killan’s test - - + - +
Bromine water test - - + - +
Proteins Xanthoproteic test - - - - -
Ninhydrin test - - - - -
Steroids Salkowski’s test + + + + -
Liebermann Burchard test + + + + -
Tannins Ferric chloride test - - - - -
Saponins Foam test - - - - +
S1 - n-hexane extract, S2 - DCM extract, S3 - methanol extract, S4 - fraction 
of methanol extract (methanol soluble), and S5 - fraction of methanol 
extract (methanol insoluble), A. farnesiana: Acacia farnesiana
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Fig. 2. Overall the results reveal that the DNA cleavage potential was 
found in the extracts of A. farnesiana pod. The activity exhibited by 
the extracts was found to be dose dependent. The fractions S4 and S5 
were found to be less potential than their extracts even though they are 
partially purified fractions of methanol extracts. The methanol extract 
is worth investigating to further fractionate using methods adopted 
for compounds of specific classes which might increase the cleavage 
potential at very low concentration and isolate compounds which might 
be having better activity than the extract.
DISCUSSION
Cancer is a deadly disease which affects a considerable number of 
people worldwide. The ongoing research is to seek out effective 
treatments for cancer including the use of medicinal plants. This 
treatment makes use of the compounds naturally present in plants that 
are known to inhibit or kill carcinogenic cells [33]. The phytochemical 
screening of the plant showed the presence of flavonoids, steroids, and 
glycosides (Table 1). Flavonoids are effective in inhibiting xanthine 
oxidase, [34] cyclooxygenase [35] enzymes. The molecular mechanism 
may involve the inhibition of the pro-oxidant process that causes 
tumor promotion. Growth promoting oxidants and reactive oxygen 
species are the major catalysts of the tumor promotion and progression 
stages and therefore inhibit tumor cell proliferation. In addition, the 
mechanism of inhibition of polyamine biosynthesis can contribute to 
the antiproliferative activities of flavonoids. Ornithine decarboxylase is 
a rate-limiting enzyme in polyamine biosynthesis and is correlated with 
the rate of DNA synthesis and cell proliferation in several tissues. Several 
experiments show that flavonoids can inhibit ornithine decarboxylase 
induced by tumor promoters causing a subsequent decrease in 
polyamine and inhibition of DNA and protein synthesis [36-38]. Cardiac 
glycosides or steroids may bind to Na+ and K+ ion ATPase results in 
complex but well-documented changes in cell signaling events. The 
“signalosome” complex includes the enzyme, Na+, K+- ATPase as well as, 
phosphoinositide-3 kinase, and phospholipase each of which, in turn, 
sets into action complex signaling events that can result in tumor cell 
death through either apoptosis or autophagy-related mechanisms [39]. 
The evaluation is carried out by dissolving the extracts in DMSO (DMSO; 
not exceeding the final concentration of 0.01 %) and further diluted in 
cell culture medium. The antiproliferative response of the extract was 
assessed by MTT assay using doxorubicin as a standard drug molecule. 
The viability of the cells was determined using a spectrophotometer at 
570 nm. The inhibitory concentration 50%, that is, the concentration 
of the extract required to inhibit cell growth by 50%, was determined. 
This study has assessed the antiproliferative and DNA cleavage 
potential of various extracts and fractions of A. farnesiana pod. The 
n-hexane (S1), DCM (S2), and methanol (S3) have shown less significant 
activity against different cell lines that are chronic myelogenous 
leukemia (K562), hepatocellular carcinoma (HePG2), breast cancer 
(MCF-7), and colorectal adenocarcinoma (Colo 205) cell lines but 
methanol and n-hexane have shown significant activity against chronic 
myelogenous leukemia (K562), hepatocellular carcinoma (HePG2), and 
breast cancer (MCF-7). From the above result, we can predict that the 
inhibition of chronic myelogenous leukemia (K562) and hepatocellular 
carcinoma (HePG2) by methanolic extract is found to be most effective 
and the inhibition of breast cancer (MCF-7) by N-Hexane extract is 
the best among the extracts screened. As the concentration of the 
sample increases, there is an increase in the cell growth inhibition for all 
the cell lines. The above findings indicate that the activity exhibited by 
the extracts might be because of their inhibitory effects of the enzymes 
by the phytochemicals. The potentiality of the extract still encourages 
for further investigation even though the extracts is having a moderate 
degree of activity.
DNA is the primary target molecule for anticancer therapies according 
to cell biology. Binding of peptides and small organic molecules to 
DNA will interfere with a number of processes like transcription and 
replication by considering this principle, various disorders such as 
cancer, and cystic fibrosis can be cured [40]. The literature survey 
reveals that the clinical efficacies of many drugs correlate with their 
ability to induce enzyme-mediated DNA cleavage. The loci present in 
the DNA are involved in various regulatory processes such as gene 
Table 2: Percentage inhibition of antiproliferative activity by 
different solvent extracts of A. farnesiana pods
Cancer cell 
lines
S1 S2 S3 Doxorubicin
K562
Average % in 6.411779 4.939444 24.53099 95.57
SD 1.067045 3.575294 2.809822 2.2256
MCF - 7
Average % in 21.70372 19.36195 17.42746 97.61
SD 3.839193 2.922661 1.760558 2.189
Colo
Average % in 4.744526 6.934307 NA 91.55
SD 3.171195 1.860956 1.8723
HepG2
Average % in 10.81081 NA 23.34152 97.355
SD 3.898994 1.890455 1.5699
S1 - n-hexane extract, S2 - DCM extract, and S3 - methanol extract, NA: Not active, 
SD: Standard deviation, A. farnesiana: Acacia farnesiana
Fig. 1: DNA cleavage potential of various solvent extracts 
of A. farnesiana pods and its fraction S4 against CT - DNA. (1-3) 
Sample S1 at 25, 50 and 100 µg, (4-6) sample S2 at 25, 50 and 
100 µg, (7-9) sample S3 at 25, 50 and 100 µg, (10-12) sample S4 at 
25, 50 and 100 µg
Fig. 2: DNA cleavage potential of fraction S5. (1-3) Sample S5 at 25, 
50, and 100 µg, M - super mix DNA Ladder (Merck, Cat # MBD21J), 
C - CT-DNA, S1 - n-hexane extract, S2 - DCM extract, S3 - methanol 
extract, S4 - fraction of methanol extract (methanol soluble), and 
S5 - fraction of methanol extract (methanol insoluble)
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expression, gene transcription, mutagenesis, and carcinogenesis [41]. 
In particular, designing of the compound having ability to cleave DNA 
is utmost important not only from the primary biological point of view 
but also in terms of photodynamic therapeutic approach to develop 
potent drugs [42]. The extracts which were found to be active in CT-DNA 
cleavage have been screened for their antiproliferative study. The DNA 
cleavage of various solvent extracts of A. farnesiana pod like n-hexane, 
DCM and methanol studied were actively cleaved, but fractions are not 
effective, hence the antiproliferative studies are conducted only for 
crude extract, viz., (S1, S2, and S3) represented in Fig. 1. The cleavage 
potential of the extracts was examined by comparing the band 
appeared in control and extracts at 100 µg concentration. The DNA 
cleavage might be through the oxidation of deoxyribose by abstraction 
of sugar hydrogen or oxidation of nucleobases. Cleavage can occur both 
at the carbohydrate and at the nucleic base levels. This mechanism 
results in the damage of all four nucleobases or the deoxyribose 
sugar. In general, hydroxyl radical species of O2 (OH) are involved. 
The phytochemical screening of extracts and fractions indicated the 
presence of flavonoids, steroids, and glycosides which contain hydroxyl 
groups in their structures may initiate them for oxidative DNA cleavage. 
The cleavage mechanism occurs in three ways hydrogen abstraction, 
addition, and electron transfer. The general accepted mechanism of 
the DNA hydrolysis reaction is a nucleophilic attack [40]. Cleavage at 
DNA phosphate backbone: To form a five coordinate intermediate, 
this can be stabilized by the catalyst. Subsequent cleavage of either 
the 3’-phosphate (as seen is most often in enzymatic systems) or the 
5’-phosphate results in a strand scission. After this nucleophilic attack, 
one group leaves as an alcohol [40]. Cleavage at deoxyribose sugar: If 
the oxidative cleavage occurs at the carbohydrate, abstraction of one 
hydrogen of deoxyribose can initiate the oxidative cleavage process. 
The oxidation at the nucleic base level occurs preferably at guanine 
because it’s lower oxidation potential. Hydroxyl radical reacts with 
the heterocyclic bases in DNA by addition. In pyrimidines, OH adds to 
the C5 or C6 double bond leading to cleavage. In purines, the cleavage 
occurs when hydroxyl ion binds to the C4, C5, and C8 [43]. The activity 
exhibited by the extracts and its fractions does not completely explain 
the mechanism of action. Based on the results obtained it can be stated 
that the flavonoids, steroids, and glycosides do contain OH functionality 
hence, might be involved in DNA cleavage as mentioned above. Further 
conclusive research needs to be carried out to attain final conclusion 
about the activity of DNA cleavage for A. farnesiana extracts.
CONCLUSION
The results obtained have shown that out of three extracts screened the 
two, viz., n- hexane and methanol of A. farnesiana pod have significant 
inhibition, and DCM has less significant on different cancer cell lines. 
The isolation of particular phytochemical from these two extracts can 
give the compound which is responsible for the inhibition of the three 
cancer cell lines chronic myelogenous leukemia (K562), hepatocellular 
carcinoma (HePG2), and breast cancer (MCF-7). The DNA cleavage 
is found to be effective with all the extracts, especially with S1 and S3 
comparing to S2, S4, and S5. Thus, A. farnesiana pod is concluded to be 
significant cytotoxic against the four cell lines mentioned above by MTT 
assay, and the DNA cleavage by various extracts and the fractions are 
found to cleave significant at all concentrations.
ACKNOWLEDGMENT
The authors are thankful to the authorities of Kuvempu University, 
for providing necessary facilities to carry out this work, Professor 
Y. L. Krishnamurthy, Department of Applied Botany Kuvempu University, 
for authentication of plant material and one of the authors S. P. Soul 
Shekhar is also thankful to OBC Cell Kuvempu University, for awarding 
OBC fellowship to carry out Ph. D. programme.
REFERENCES
1. Gennari C, Castoldi D, Sharon O. Natural products with taxol-like anti-
tumor activity: Synthetic approaches to eleutherobin and dictyostatin. 
Pure Appl Chem 2007;79(2):173-80.
2. Nishanthi M, Prasanthi P, Muni TK, Kumar RK, Nishanthi P, 
Nagendramma M, et al. A cancer disease: A review. Asian J Pharm Res 
2013;3(1):47-52.
3. Global Cancer Facts and Figures. 3rd ed. Atlanta: American Cancer 
Society; 2015. Available from: https://www.cancer.org/research/cancer-
facts-statistics/global.html.
4. Dai J, Mumper RJ. Plant phenolics: Extraction, analysis and their 
antioxidant and anticancer properties. Molecules 2010;15(10):7313-52.
5. Nostro A, Germano MP, Angelo VD, Marino A, Cannatelli MA. 
Extraction methods and bioautography for evaluation of medicinal 
plant antimicrobial activity. Lett Appl Microbiol 2000;30(5):379-84.
6. Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical constituents of 
some Nigerian medicinal plants. Afr J Biotechnol 2005;4(7):685-8.
7. Kaur R, Kapoor K, Kaur H. Plants as a source of anticancer agents. 
J Nat Prod Plant Resour 2011;1(1):119-24.
8. Harun-ur-Rashid M, Gafur MA, Golam S, Aziz AR. Biological 
activities of a new acrylamide derivative from Ipomoea turpethum. Pak 
J Biol Sci 2002;5(9):968-9.
9. Bino K, Saminathan K, Pemaiah B, Appian S. Pharmacodynamic 
studies on the isolated active fraction of Acacia farnesiana (L.) Willd. 
Pharmacogn Mag 2014;10 Suppl S2:S283-7.
10. Duke JA. Handbook of Legumes of World Economic Importance. 
1st ed. New York: Plenum Press; 1981.
11. Santos G, Ginebra A, Cristina R, Norma H. Extracts of Acacia 
farnesiana and Artemisia ludoviciana inhibit growth, enterotoxin 
production and adhesion of Vibrio cholera. World J Microbiol 
Biotechnol 2006;22:669-74.
12. Allan S, Adkins S. Searching for a Natural Herbicide: The Role of 
Medicinal Plants. School of Land and Food Science, University of 
Queensland, St. Lucia Qld 4072. Available from: http://www.regional.
org.au/au/allelopathy/2005/2/7/2680_allans.htm.
13. Garavito G, Rincon J, Arteaga L, Hata Y, Bourdy G, Gimenez A, 
et al. Antimalarial activity of some colombian medicinal plants. 
J Ethnopharmacol 2006;107(3):460-2.
14. Salfarina R, Ken-Ichi H, Nijsiri R. Antioxidant, antimicrobial and 
cytotoxicity activities of Acacia farnesiana (L.) Willd. Leaves ethanolic 
extract. Pharmacogn J 2011;3(23):50-8.
15. de la Steve C, Eduardo R, Hortencia ND, Adela AV. Acute toxicity and 
decreased peristalsis in mice caused by Taxodium mucronatum and 
Acacia farnesiana extracts. Rev Latinoam Quím 2012;40(1):19-25.
16. Thirupal RB, Varaprasad B, Moulali DA. Antimicrobial screening of 
Acacia farnesiana (L.) Willd. Indian J Bot Res 2008;4(2):249-51.
17. Amalia MM, Ernesto FT, Fernando RC, Tania LV. Lead bioaccumulation 
in Acacia farnesiana and its effect on lipid peroxidation and glutathione 
production. Plant Soil 2011;339(1):377-89.
18. Hanumantharao Y, Medikondu K, Ravindhranath K. Characterization 
an defluoridation studies using activated Acacia farnesiana carbon as 
adsorbent. Electron J Environ Agric Food Chem 2012;11:442-58.
19. Dwarakanath V, Dhanasree B, Jayasimha GB, Nizamuddin BS. 
Antiulcer activity of Acacia farnesiana (L) (aroma) a lesser known 
folk - Medicinal plant. Int J Pharm Bio Sci 2013;3:145-52.
20. Nashrin T, Syahiran R. Inhibition of acetylcholine esterase and NADH 
oxidase by Acacia farnesiana. Panacea J Pharm Pharm Sci 2012;1:6-8.
21. Trivedi CP, Modi NT, Sarin RK, Rao SS. Bronchodilator and anti-
inflammatory effect of glycosidal fraction of Acacia farnesiana. Indian 
J Physiol Pharm 1986;30(3):267-8.
22. Abrantes VE, Rocha BA, Nóbrega RB, Silva-Filho JC, Teixeira CS, 
Cavada BS, et al. Molecular modeling of lectin-like protein from 
Acacia farnesiana reveals a possible anti-inflammatory mechanism in 
carrageenan-induced inflammation. BioMed Res Int 2013;2013:253483.
23. Kariyappa SK, Kallappa MH. Occurrence of cyclopropenoid fatty acids 
in Acacia farnesiana seed oil and its possible industrial utilization. 
Indian J Appl Res 2013;3:72-4.
24. Shen LA, Rong LC, Chi DY, Tilo L, Michael YC, Chenb IH, et al. 
Acasiane A and B and farnesirane A and B, diterpene derivatives from 
the roots of Acacia farnesiana. Plant Med 2009;75(3):256-61.
25. Sanchez E, Heredia N, Mdel RC, Garcia S. Isolation, characterization 
and mode of antimicrobial action against Vibrio cholerae of 
methyl gallate isolated from Acacia farnesiana. J Appl Microbiol 
2013;115(6):1307-16.
26. Heba HB, Ahmed MS, Sahar AM, Ola AI, Mahmoud AM. Flavonoid 
galloyl glucosides from the pods of Acacia farnesiana. Phytochemistry 
1999;51(1):139-42.
27. Satyanarayan ND, Al-Baadani WA, Shekhar SP, Harishkumar S. Anti-
tubercular activity of various solvent extracts of Acalypha indica L. 
Against drug susceptible H37Rv strain. World J Pharm Pharm Sci 
2016;5(8):957-65.
201
Asian J Pharm Clin Res, Vol 10, Issue 9, 2017, 197-201
 Shekhar et al. 
28. Trease GE, Evans WC. A Textbook of Pharmacognosy. 14th ed. London: 
Bailliere Tindall Ltd.; 1996.
29. Harborne JB. Phytochemical Methods: A Guide to Modern Techniques 
of Plant Analysis. 3rd ed. London: Chapman and Hall; 1998.
30. Manjunatha KS, Manjulatha K, Satyanarayan ND, Kaviraj MY, 
Adarsha HJ. Anti-proliferative and ADMET screening of novel 
3-(1H-indol-3-yl)-1, 3-diphenylpropan-1-one derivatives. Cogent 
Chem 2016;2:1172542.
31. Anantacharya R, Manjulatha K, Satyanarayan ND, Santoshkumar S, 
Kaviraj MY. Antiproliferative, DNA cleavage, and ADMET study of 
substituted 2-(1-benzofuran-2-yl) quinoline-4-carboxylic acid and its 
esters. Cogent Chem 2016;2:1158382.
32. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory 
Manual. 2nd ed. New York: Cold Spring Harbor Laboratory; 1989.
33. Umadevi M, Kumar KP, Bhowmik D, Duraivel S. Traditionally used 
anticancer herbs in India. J Med Plant Stud 2013;1(3):56-74.
34. Chang WS, Lee YJ, Lu FJ, Chiang HC. Inhibitory effects of flavonoids 
on xanthine oxidase. Anticancer Res 1993;13(6A):2165-70.
35. Mutoh M, Takahashi M, Fukuda K, Komatsu H, Enya T, 
Matsushima HY, et al. Suppression by flavonoids of cyclooxygenase-2 
promoter-dependent transcriptional activity in colon cancer cells: 
Structure-activity relationship. Jpn J Cancer Res 2000;91(7):686-91.
36. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, et al. 
Chemoprevention of azoxymethane-induced rat colon carcinogenesis 
by the naturally occurring flavonoids, diosmin and hesperidin. 
Carcinogenesis 1997;18(5):957-65.
37. Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, Hara A, 
et al. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral 
carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone 
and in combination. Cancer Res 1997;57(2):246-52.
38. Makita H, Tanaka T, Fujitsuka H, Tatematsu N, Satoh K, Hara A, 
et al. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral 
carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, 
and quercetin. Cancer Res 1996;56(21):4904-9.
39. Robert AN, Peiying Y, Alison DP, Keith IB. Cardiac glycosides as novel 
cancer therapeutic agents. Mol Invent 2008;8(1):36-49.
40. Gowda KR, Blessy BM, Sudhamani CN, Naik HS. Mechanism of DNA 
binding and cleavage. Biomed Biotechnol 2014;2(1):1-9.
41. Sreelatha S, Padma PR, Umadevi M. Protective effects of Coriandrum 
sativum extracts on carbon tetrachloride-induced hepatotoxicity in rats. 
Food Chem Toxicol 2009;47(4):702-8.
42. Kumar V, Kaur K, Karelia DN, Beniwal V, Gupta GK, 
Arun KS, et al. Synthesis and biological evaluation of some 2-(3, 
5-dimethyl-1H-pyrazol-1-yl)-1 arylethanones: Antibacterial, 
DNA photocleavage, and anticancer activities. Eur J Med Chem 
2014;81:267-76.
43. Kochetkov NK, Budovskii EI. Reactions involving the cleavage or 
rearrangement of heterocyclic rings of nucleic acid bases and their 
derivatives. Organic Chemistry of Nucleic Acids. 1st ed. London: 
Plenum Publishing Company Ltd.; 1972.
